Ashish Mahajan, Partner in Deloitte’s Life Sciences and Healthcare Consulting Practice in Southeast Asia, outlines some of the key trends playing out in the region, the extent to which the COVID-19 pandemic has sped up the industry’s digitalisation efforts, and how Asian innovation stands to develop in the coming years.
Companies are becoming increasingly mature and want to extend value for dollars spent. The progress that has been made on digital in life sciences and healthcare industry in the last 18 months is equivalent to that which has been made in the last five years
